SG10201708577PA - Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin - Google Patents
Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrinInfo
- Publication number
- SG10201708577PA SG10201708577PA SG10201708577PA SG10201708577PA SG10201708577PA SG 10201708577P A SG10201708577P A SG 10201708577PA SG 10201708577P A SG10201708577P A SG 10201708577PA SG 10201708577P A SG10201708577P A SG 10201708577PA SG 10201708577P A SG10201708577P A SG 10201708577PA
- Authority
- SG
- Singapore
- Prior art keywords
- lactoferrin
- probiotic
- compositions
- mineral salts
- prebiotic components
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A000019A IT1392672B1 (en) | 2009-01-12 | 2009-01-12 | COMPOSITIONS INCLUDING PROBIOTIC COMPONENTS AND PREBIOTICS AND MINERAL SALTS, WITH LACTOFERRINA |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201708577PA true SG10201708577PA (en) | 2017-11-29 |
Family
ID=41404578
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201708577PA SG10201708577PA (en) | 2009-01-12 | 2010-01-12 | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
SG10201912981XA SG10201912981XA (en) | 2009-01-12 | 2010-01-12 | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
SG2011045663A SG172314A1 (en) | 2009-01-12 | 2010-01-12 | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201912981XA SG10201912981XA (en) | 2009-01-12 | 2010-01-12 | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
SG2011045663A SG172314A1 (en) | 2009-01-12 | 2010-01-12 | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP2385837B1 (en) |
JP (1) | JP5832297B2 (en) |
KR (1) | KR101353692B1 (en) |
CN (1) | CN102341113B (en) |
AR (1) | AR075015A1 (en) |
AU (1) | AU2010203367B2 (en) |
BR (1) | BRPI1006147B1 (en) |
CA (1) | CA2748200C (en) |
CO (1) | CO6410310A2 (en) |
DK (1) | DK2385837T3 (en) |
ES (1) | ES2652464T3 (en) |
HU (1) | HUE035426T2 (en) |
IL (1) | IL213677A (en) |
IT (1) | IT1392672B1 (en) |
MX (1) | MX2011007348A (en) |
MY (1) | MY183800A (en) |
NO (1) | NO2385837T3 (en) |
NZ (1) | NZ593708A (en) |
PL (1) | PL2385837T3 (en) |
PT (1) | PT2385837T (en) |
RU (2) | RU2536939C2 (en) |
SG (3) | SG10201708577PA (en) |
TW (2) | TWI574633B (en) |
WO (1) | WO2010081126A2 (en) |
ZA (1) | ZA201105881B (en) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010081913A2 (en) * | 2009-01-19 | 2010-07-22 | Université De Liège Gembloux Agro-Bio Tech | A process for the production of a composition, the composition and the use thereof as food additive |
ITBO20090070A1 (en) * | 2009-02-12 | 2010-08-12 | Monica Bonucci | DRUG FOR AFTOSA STOMATITIS |
AU2011351420A1 (en) * | 2010-12-29 | 2013-07-18 | Nestec S.A. | Fiber and probiotics for reducing intestinal symptoms related to chronic stress |
MX2013007736A (en) * | 2010-12-29 | 2013-07-24 | Nestec Sa | A nutritional composition comprising fiber and probiotics for reducing stress-related intestinal symptoms. |
US20130280225A1 (en) * | 2010-12-29 | 2013-10-24 | Nestec S.A. | Fiber and probiotics for reducing intestinal symptoms related to stress |
WO2012118535A1 (en) * | 2011-03-01 | 2012-09-07 | Quorum Innovations, Llc | Materials and methods for treating conditions associated with pathogenic biofilm |
TWI386215B (en) * | 2011-05-16 | 2013-02-21 | Promd Biotech Co Ltd | A composition for preventing necrotizing enterocolitis |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
KR101453982B1 (en) * | 2012-09-19 | 2014-10-28 | 주식회사 쎌바이오텍 | Composition for preventing or treating irritable bowel syndrome |
US20140255365A1 (en) * | 2013-03-11 | 2014-09-11 | Mead Johnson Nutrition Company | Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
EA034376B1 (en) * | 2013-07-05 | 2020-01-31 | Интегра Медикал Инк. | Oral care compositions |
US9271694B2 (en) * | 2013-12-18 | 2016-03-01 | General Electric Company | System and method of simplifying a direct control scheme for a detector |
JP2017506637A (en) * | 2014-02-14 | 2017-03-09 | ヴァサル ファルマ ソシエテ アノニム | Composition comprising Bifidobacterium animalis subsp. Lactis |
WO2015121458A2 (en) * | 2014-02-14 | 2015-08-20 | Vesale Pharma Sa | Composition comprising bifidobacterium animalis ssp. lactis |
EP2992894A1 (en) * | 2014-09-05 | 2016-03-09 | Progine Farmaceutici Srl | Vaginal formulations for preventing and treating vaginal and cervico-vaginal infections |
MX2017003293A (en) * | 2014-09-30 | 2017-06-21 | Kimberly Clark Co | Synergistic prebiotic composition. |
KR20170091157A (en) | 2014-12-23 | 2017-08-08 | 4디 파마 리서치 리미티드 | Pirin polypeptide and immune modulation |
SI3065748T1 (en) | 2014-12-23 | 2018-05-31 | 4D Pharma Research Limited | A bacteroides thetaiotaomicron strain and its use in reducing inflammation |
ES2575828B1 (en) * | 2014-12-31 | 2017-07-07 | Universidad De León | Use of probiotics in increasing male fertility |
MA41010B1 (en) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
KR20180012849A (en) | 2015-06-15 | 2018-02-06 | 4디 파마 리서치 리미티드 | Composition Containing Bacterial Strain |
ES2742514T3 (en) | 2015-06-15 | 2020-02-14 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
MA41060B1 (en) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
AU2016278067B2 (en) | 2015-06-15 | 2022-09-22 | Cj Bioscience, Inc. | Compositions comprising bacterial strains |
RU2593584C1 (en) * | 2015-07-22 | 2016-08-10 | Игорь Юрьевич Чичерин | Agent for reduction of intestinal microbiocenosis in case of dysbiosis |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
PT3209310T (en) | 2015-11-20 | 2018-04-20 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
CA3016179C (en) | 2016-03-04 | 2019-08-13 | 4D Pharma Plc | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity |
TWI802545B (en) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | Compositions comprising bacterial strains |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
IT201600131819A1 (en) * | 2016-12-28 | 2018-06-28 | Metis Healthcare S R L | PREPARATION FOR ORAL SPRAY |
CN106722206A (en) * | 2017-01-09 | 2017-05-31 | 广州能靓生物技术有限公司 | A kind of composition for alleviating alimentary canal malaise symptoms and/or emotional stress and products thereof |
CN106820156A (en) * | 2017-02-17 | 2017-06-13 | 福建康是美生物科技有限公司 | A kind of probiotic composition of regulating intestinal canal flora health |
JP6766253B2 (en) * | 2017-03-28 | 2020-10-07 | 森永乳業株式会社 | New Bifidobacterium spp. |
EP3630137B1 (en) | 2017-05-22 | 2023-05-17 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
MA41708A (en) | 2017-05-24 | 2020-04-08 | 4D Pharma Res Ltd | COMPOSITIONS CONTAINING BACTERIAL STRAINS |
MD3600364T2 (en) | 2017-06-14 | 2020-12-31 | 4D Pharma Res Ltd | Compositions comprising a bacterial strain of the genus Megasphaera and uses thereof |
ES2841902T3 (en) | 2017-06-14 | 2021-07-12 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
ES2855701T3 (en) | 2017-06-14 | 2021-09-24 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
US20190076497A1 (en) * | 2017-09-11 | 2019-03-14 | Kenneth Davin Fine | Oral and intestinal health products |
IT201800003128A1 (en) * | 2018-02-28 | 2019-08-28 | Propharma Soc A Responsabilita Limitata Semplificata | PROBIOTIC COMPOSITION |
FR3078610B1 (en) * | 2018-03-08 | 2020-02-21 | Abcd Nutrition | COMPOSITION OF SPECIAL PROBIOTICS AND USE FOR REDUCING DIGESTIVE INFLAMMATORY SYMPTOMS |
FR3078609B1 (en) * | 2018-03-08 | 2020-02-21 | Abcd Nutrition | COMPOSITION FOR DECREASING GLUTEN SENSITIVITY |
WO2019173763A1 (en) * | 2018-03-09 | 2019-09-12 | Biohm Health Llc | Compositions for use in balancing microbiome |
CN108902981A (en) * | 2018-04-25 | 2018-11-30 | 深圳市多微生保健食品有限公司 | A kind of probiotic composition and probiotics solid beverage |
CN109198646A (en) * | 2018-10-29 | 2019-01-15 | 广州普维君健药业有限公司 | Have effects that prevent and treat the probiotic composition of bowl inflammatory diseases and its application |
WO2020150672A2 (en) * | 2019-01-18 | 2020-07-23 | Mars, Incorporated | Methods and compositions for treating intestinal dysbiosis |
CN110236065A (en) * | 2019-07-29 | 2019-09-17 | 广东格物生物科技有限公司 | A kind of probiotics solid beverage and preparation method thereof |
IT202000005011A1 (en) * | 2020-03-09 | 2021-09-09 | Sofar Spa | Lactoferrin for oral use with antiviral action |
MX2022010877A (en) * | 2020-03-09 | 2023-01-04 | Sofar Spa | Bacterial strains and compositions thereof for oral use in the treatment of viral infections of the respiratory system. |
CN111528486A (en) * | 2020-05-19 | 2020-08-14 | 仙乐健康科技股份有限公司 | Composition containing lactoferrin |
US20240299292A1 (en) * | 2020-12-01 | 2024-09-12 | Seattle Gummy Company | Stable semi-solid chewable gel compositions and methods of making and using thereof |
IT202100001067A1 (en) * | 2021-01-21 | 2022-07-21 | Nutraceutical Tech Pharma Biotech Srl | NUTRACEUTICAL COMPOSITION FOR THE TREATMENT OF PATHOLOGIES RELATED TO CHEMOTHERAPY |
WO2022196488A1 (en) * | 2021-03-15 | 2022-09-22 | 森永乳業株式会社 | Composition for improving qol |
CN114057904B (en) * | 2021-11-03 | 2023-04-28 | 沈阳农业大学 | Sulfhydryl radix Codonopsis polysaccharide and application thereof in preparation of colon targeting probiotic microcapsule |
CN115518121B (en) * | 2022-09-28 | 2023-10-20 | 广州能靓生物技术有限公司 | Composition containing probiotics and application thereof |
WO2024072421A1 (en) * | 2022-09-30 | 2024-04-04 | Bonafide Health, Llc | Probiotic and folic acid compositions and methods of using |
CN117018169A (en) * | 2023-10-07 | 2023-11-10 | 广州菲勒生物科技有限公司 | Nutritional composition preparation for preventing respiratory tract virus infection |
CN117025488B (en) * | 2023-10-09 | 2024-03-08 | 广东益可维生物技术有限公司 | Technological method for improving intestinal tract colonization rate of probiotics and probiotics freeze-dried powder |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6241983B1 (en) * | 1994-10-28 | 2001-06-05 | Metagenics, Inc. | Bacteria-and fiber-containing composition for human gastrointestinal health |
CA2334370A1 (en) * | 1998-06-05 | 1999-12-16 | Nobuyuki Suzuki | Lactic acid bacterium-containing compositions, drugs and foods |
US7214370B2 (en) * | 2000-12-18 | 2007-05-08 | Probiohealth, Llc | Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
CA2503510C (en) * | 2002-09-26 | 2014-12-02 | Probiohealth, Llc | Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
RU2264450C2 (en) * | 2003-10-08 | 2005-11-20 | Закрытое Акционерное Общество "Биокад" | Biopreparation for adults useful in prophylaxis and treatment of dysbacteriosis and infective diseases of gastrointenstinal tract in human of 12 years old or more |
US20060093592A1 (en) * | 2004-10-04 | 2006-05-04 | Nutracea | Synbiotics |
ITMI20062031A1 (en) * | 2006-10-23 | 2008-04-24 | Velleja Res Srl | COMPOSITIONS FOR THE PREVENTION OF DEPAUPERAMENTO OF THE INTESTINAL FLORA AND OF THE DAMAGE OF ORGAN SUBSEQUENT TO ANTIBIOTIC THERAPY |
TW200846466A (en) * | 2007-05-25 | 2008-12-01 | yong-yu Lai | Probiotic powder composition and product thereof |
-
2009
- 2009-01-12 IT ITMI2009A000019A patent/IT1392672B1/en active
-
2010
- 2010-01-12 CN CN201080010567.7A patent/CN102341113B/en active Active
- 2010-01-12 TW TW099100714A patent/TWI574633B/en active
- 2010-01-12 BR BRPI1006147-9A patent/BRPI1006147B1/en active IP Right Grant
- 2010-01-12 MY MYPI2011003226A patent/MY183800A/en unknown
- 2010-01-12 AR ARP100100070A patent/AR075015A1/en unknown
- 2010-01-12 HU HUE10700778A patent/HUE035426T2/en unknown
- 2010-01-12 DK DK10700778.3T patent/DK2385837T3/en active
- 2010-01-12 KR KR1020117018737A patent/KR101353692B1/en active IP Right Grant
- 2010-01-12 RU RU2011128133/10A patent/RU2536939C2/en active
- 2010-01-12 NZ NZ593708A patent/NZ593708A/en unknown
- 2010-01-12 PT PT107007783T patent/PT2385837T/en unknown
- 2010-01-12 SG SG10201708577PA patent/SG10201708577PA/en unknown
- 2010-01-12 SG SG10201912981XA patent/SG10201912981XA/en unknown
- 2010-01-12 ES ES10700778.3T patent/ES2652464T3/en active Active
- 2010-01-12 CA CA2748200A patent/CA2748200C/en active Active
- 2010-01-12 EP EP10700778.3A patent/EP2385837B1/en active Active
- 2010-01-12 PL PL10700778T patent/PL2385837T3/en unknown
- 2010-01-12 TW TW105133803A patent/TWI633846B/en active
- 2010-01-12 JP JP2011545503A patent/JP5832297B2/en active Active
- 2010-01-12 NO NO10700778A patent/NO2385837T3/no unknown
- 2010-01-12 MX MX2011007348A patent/MX2011007348A/en unknown
- 2010-01-12 SG SG2011045663A patent/SG172314A1/en unknown
- 2010-01-12 AU AU2010203367A patent/AU2010203367B2/en active Active
- 2010-01-12 WO PCT/US2010/020712 patent/WO2010081126A2/en active Application Filing
-
2011
- 2011-06-20 IL IL213677A patent/IL213677A/en active IP Right Grant
- 2011-08-11 ZA ZA2011/05881A patent/ZA201105881B/en unknown
- 2011-08-11 CO CO11102361A patent/CO6410310A2/en not_active Application Discontinuation
-
2014
- 2014-10-06 RU RU2014140223A patent/RU2014140223A/en not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201105881B (en) | Compositions comprising probiotic and prebiotic components and mineral salts,with lactoferrin | |
SG11201602868WA (en) | Probiotic stabilization | |
ZA201209259B (en) | Uses and compositions | |
PL2900805T3 (en) | Probiotic and prebiotic compositions | |
EP2476717A4 (en) | Polyamide and polyamide composition | |
GB0905488D0 (en) | Organopolysiloxane compositions and their production | |
HK1185368A1 (en) | Heat-curable polyorganosiloxane composition and use thereof | |
EP2490543A4 (en) | Extracts, fractions and compositions comprising acetogenins and their applications | |
EP2405770A4 (en) | Compositions comprising monatin and calcium | |
EP2517711A4 (en) | Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages | |
GB0915796D0 (en) | Polymerase compositions and uses | |
HK1169306A1 (en) | Composition having lipolysis-promoting effect | |
GB0911350D0 (en) | Particulate composition | |
EP2438173A4 (en) | Biomaterials, compositions, and methods | |
BR112012003860A2 (en) | Combination and nutritional composition | |
PL2672837T3 (en) | Nutritional compositions and uses thereof | |
ZA201107768B (en) | Prebiotic composition | |
GB0901494D0 (en) | Compositions and Methods | |
GB0909792D0 (en) | Composition and uses thereof | |
GB0902873D0 (en) | Prebiotic combination | |
GB0901899D0 (en) | Compositions and uses | |
GB0920870D0 (en) | Trans-membrane transfer compositions and methods | |
GB201019291D0 (en) | Compositions and uses | |
GB201020268D0 (en) | Composition and uses | |
GB0909720D0 (en) | Compositions and methods |